Ministry of Food and Drug Safety supports commercialization of new technology gene therapy products

News Consumer protection General Updates

Date: 20th Dec, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On December 20, 2024, the Korea Food and Drug Administration (KFDA) announced the release of a guideline for the development of CAR-T cell therapy products. The guideline aims to support domestic pharmaceutical companies in developing safe and effective CAR-T cell therapies, providing general considerations for designing and developing CAR-T cell therapies, as well as quality evaluation, non-clinical and clinical trial recommendations."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Ministry of Food and Drug Safety supports commercialization of new technology gene therapy products

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Ministry of Food and Drug Safety supports commercialization of new technology gene therapy products

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.